September 10, 2020

Pilz Biosciences Corp enters into Master Services Agreement (MSA) with Comac Medical Ltd. (Comac), Sophia, Bulgaria – an international clinical research/site management company engaged in trial monitoring, bioanalysis, GxP auditing, and biometrics. Comac will assist Pilz in designing and performing pharmacokinetic and Phase 1 clinical studies, as well as assist in European regulatory filings for drug approval.